According to the presented data, we reasoned that if MYPT1 acts as a tumor suppressor that regulates the stem-like properties of ovarian cancer, then we should observe low expression levels of MYPT1 in tumorspheres compared to those in total cell extracts. Here, PPP1R12A is linked to ovarian cancer.